Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy.
Journal Information
Full Title: Acta Pharm Sin B
Abbreviation: Acta Pharm Sin B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest The authors have no conflicts of interest to declare."
"This work was financially supported by the 10.13039/501100001809National Natural Science Foundation of China (21874066, and 82073288), the National Key R&D Program of China (2019YFA0709200), the Key Research and Development Program of Jiangsu Province (BE2021373, China), Jiangsu Provincial Medical Key Discipline Cultivation Unit (JSDW202239, China), the 10.13039/501100004608Natural Science Foundation of Jiangsu Province (BK20200336, China), the Fundamental Research Funds for Central Universities (China), the Program for Innovative Talents and Entrepreneur in Jiangsu (China), and Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX23_0146, China)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025